UHS

181.33

2.62% 4.63

Handel nachbörslich: 181.33

Universal Health Services Inc (UHS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$176.70

Offen:

$176

24-Stunden-Volumen:

654.59K

Relative Volume:

0.85

Marktkapitalisierung:

$11.08B

Einnahmen:

$17.36B

Nettoeinkommen (Verlust:

$1.51B

KGV:

7.833

EPS:

23.1495

Netto-Cashflow:

$849.25M

1W Leistung:

-0.42%

1M Leistung:

-5.88%

6M Leistung:

-12.33%

1J Leistung:

+3.90%

1-Tages-Spanne:

$175.75

$181.52

1-Wochen-Bereich:

$173.79

$183.82

52-Wochen-Spanne:

$152.33

$246.32

Universal Health Services Inc Stock (UHS) Company Profile

Firmenname

Universal Health Services Inc

Sektor

Healthcare (1116)

Branche

Medical Care Facilities (54)

Telefon

(610) 768-3300

Adresse

367 S GULPH RD, KING OF PRUSSIA, PA

Mitarbeiter

101,500

Twitter

@uhs_inc

Nächster Verdiensttermin

2026-04-27

Neueste SEC-Einreichungen

UHS's Discussions on Twitter

Compare UHS vs HCA, THC, FMS, ENSG

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
UHS Universal Health Services Inc	181.33	10.79B	17.36B	1.51B	849.25M	23.15
HCA Hca Healthcare Inc	483.92	105.49B	75.60B	7.78B	7.69B	28.38
THC Tenet Healthcare Corp	190.28	16.36B	21.31B	2.37B	2.53B	15.49
FMS Fresenius Medical Care Ag Adr	22.48	12.52B	22.18B	1.36B	2.00B	1.9216
ENSG Ensign Group Inc	197.98	11.43B	5.06B	344.26M	370.71M	5.8446

Universal Health Services Inc Stock (UHS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-01-07	Herabstufung	Wells Fargo	Overweight → Equal Weight
2025-11-03	Hochstufung	Raymond James	Mkt Perform → Outperform
2025-10-14	Fortgesetzt	Goldman	Neutral
2025-07-16	Herabstufung	BofA Securities	Neutral → Underperform
2025-04-15	Herabstufung	Robert W. Baird	Outperform → Neutral
2025-03-26	Eingeleitet	Morgan Stanley	Equal-Weight
2025-02-03	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2024-12-17	Fortgesetzt	JP Morgan	Neutral
2024-12-16	Herabstufung	Goldman	Buy → Neutral
2024-11-06	Fortgesetzt	BofA Securities	Neutral
2024-10-16	Hochstufung	TD Cowen	Hold → Buy
2024-10-11	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2024-07-26	Hochstufung	Barclays	Equal Weight → Overweight
2024-07-26	Hochstufung	Cantor Fitzgerald	Underweight → Neutral
2024-06-26	Hochstufung	Robert W. Baird	Neutral → Outperform
2024-05-30	Eingeleitet	Robert W. Baird	Neutral
2024-05-20	Hochstufung	UBS	Neutral → Buy
2024-03-06	Eingeleitet	Barclays	Equal Weight
2024-01-02	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-12-11	Hochstufung	Goldman	Sell → Buy
2023-06-02	Hochstufung	BofA Securities	Neutral → Buy
2023-05-30	Hochstufung	SVB Securities	Market Perform → Outperform
2023-04-25	Hochstufung	Barclays	Underweight → Equal Weight
2023-04-21	Eingeleitet	Cantor Fitzgerald	Underweight
2023-04-19	Eingeleitet	JP Morgan	Neutral
2023-03-01	Herabstufung	Wolfe Research	Outperform → Peer Perform
2023-01-24	Hochstufung	UBS	Sell → Neutral
2023-01-03	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-12-16	Hochstufung	BofA Securities	Underperform → Neutral
2022-07-06	Herabstufung	BMO Capital Markets	Market Perform → Underperform
2022-06-17	Eingeleitet	Loop Capital	Hold
2022-03-29	Eingeleitet	Wells Fargo	Underweight
2022-02-28	Herabstufung	Seaport Research Partners	Buy → Neutral
2022-01-10	Fortgesetzt	Citigroup	Buy
2021-09-24	Eingeleitet	UBS	Sell
2021-09-10	Eingeleitet	Cowen	Market Perform
2021-09-08	Herabstufung	Goldman	Neutral → Sell
2021-08-12	Herabstufung	Barclays	Overweight → Underweight
2021-07-09	Eingeleitet	Seaport Global Securities	Buy
2021-06-10	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2021-01-05	Herabstufung	BofA Securities	Neutral → Underperform
2020-12-15	Eingeleitet	Goldman	Neutral
2020-09-21	Herabstufung	JP Morgan	Neutral → Underweight
2020-06-09	Hochstufung	Barclays	Equal Weight → Overweight
2020-03-23	Herabstufung	BofA/Merrill	Buy → Neutral
2019-07-26	Bestätigt	BofA/Merrill	Buy
2019-03-04	Herabstufung	JP Morgan	Overweight → Neutral
2019-01-14	Eingeleitet	Stephens	Equal-Weight
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2018-11-16	Eingeleitet	UBS	Buy
2018-09-18	Hochstufung	BofA/Merrill	Neutral → Buy
2018-07-18	Herabstufung	Goldman	Buy → Neutral
2018-01-30	Fortgesetzt	Wells Fargo	Outperform
2018-01-03	Eingeleitet	Goldman	Buy
2018-01-03	Herabstufung	Piper Jaffray	Overweight → Neutral
2017-12-12	Hochstufung	Citigroup	Neutral → Buy
2017-10-11	Eingeleitet	Stephens	Equal-Weight
2017-06-07	Eingeleitet	Morgan Stanley	Equal-Weight
2017-04-27	Bestätigt	RBC Capital Mkts	Outperform
2017-04-05	Eingeleitet	Deutsche Bank	Buy
2017-03-27	Hochstufung	Mizuho	Neutral → Buy

Alle ansehen

Universal Health Services Inc Aktie (UHS) Neueste Nachrichten

05:47 AM

Universal Health Services vows to stabilize Cedar Hill amid patient safety concerns, staffing woes - The Business Journals

05:47 AM

05:45 AM

One year in, DC’s newest hospital faces growing pains and public scrutiny - WUSA9

05:45 AM

04:14 AM

Universal Health Services to post Q1 results April 27, hold call April 28 - Stock Titan

04:14 AM

11:36 AM

4 Stocks to Watch in a Rapidly Transforming Hospital Industry - Yahoo! Finance Canada

11:36 AM

07:50 AM

'Significant issues' at Cedar Hill hospital under scrutiny during DC roundtable - WJLA

07:50 AM

03:26 AM

Allspring Global Investments Holdings LLC Sells 12,378 Shares of Universal Health Services, Inc. $UHS - marketbeat.com

03:26 AM

Apr 04, 2026

Universal Health Services, Inc. (NYSE:UHS) Receives Average Rating of "Hold" from Analysts - marketbeat.com

Apr 04, 2026

Universal Health Services (NYSE:UHS) Cut to "Hold" at Wall Street Zen - marketbeat.com

Apr 04, 2026

Apr 02, 2026

Universal Health Services' Q1 2026 earnings: What to expect - MSN

Apr 02, 2026

Deposit Central School students get hands-on medical experience - thedailystar.com

Apr 02, 2026

Universal Health Services' Q1 2026 Earnings: What to Expect - Barchart.com

Apr 02, 2026

Vista Investment Partners LLC Purchases New Stake in Universal Health Services, Inc. $UHS - marketbeat.com

Apr 02, 2026

Ambulatory Healthcare Service Market Size 2026 Emerging - openpr.com

Apr 02, 2026

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report - Benzinga

Apr 02, 2026

Apr 01, 2026

Sysco and Boston Scientific is the most oversold U.S. large-cap stock (DG:NYSE) - Seeking Alpha

Apr 01, 2026

Signed and Scrubbed: March 2026 hospital M&A - Healthcare Brew

Apr 01, 2026

Healthcare Reclaims No. 1 Spot On Americans' List Of Worries As Financial Strain Grows - Benzinga

Apr 01, 2026

Access won't guarantee health: the silent gap in universal healthcare coverage - IOL

Apr 01, 2026

Universal Health Services Stock: A Comprehensive Look at Business Model, Growth Drivers, and Investo - AD HOC NEWS

Apr 01, 2026

BTC Capital Management Inc. Boosts Stock Holdings in Universal Health Services, Inc. $UHS - marketbeat.com

Apr 01, 2026

Mar 31, 2026

Universal Health Services Inc. Cl B stock underperforms Tuesday when compared to competitors - MarketWatch

Mar 31, 2026

Trump's Medicaid Rollback Could Put Hundreds Of Hospitals In Peril, New Report Finds - Benzinga

Mar 31, 2026

Mar 30, 2026

Universal Health Services (UHS) Announces 2026 Executive Incenti - GuruFocus

Mar 30, 2026

Universal Health (NYSE: UHS) EVP gets 6,404 restricted stock units - Stock Titan

Mar 30, 2026

UHS (NYSE: UHS) EVP granted 5,627 restricted stock units vesting through 2030 - Stock Titan

Mar 30, 2026

Universal Health Services (UHS) chair granted 14,153 Class B share units as RSUs - Stock Titan

Mar 30, 2026

Universal Health Services Inc. Cl B stock underperforms Monday when compared to competitors - MarketWatch

Mar 30, 2026

A Look At Universal Health Services (UHS) Valuation After Recent Share Price Weakness - simplywall.st

Mar 30, 2026

At US$184, Is Universal Health Services, Inc. (NYSE:UHS) Worth Looking At Closely? - 富途牛牛

Mar 30, 2026

Is Universal Health Services (UHS) Still Attractive After Recent Share Price Pullback? - Yahoo Finance

Mar 30, 2026

Universal Health Services Stock: Business Model, Growth Drivers, and Investor Outlook in a Resilient - AD HOC NEWS

Mar 30, 2026

Consultation launched to review medical professionals - Healthcare Today

Mar 30, 2026

Mar 29, 2026